103 related articles for article (PubMed ID: 10737726)
1. Enzyme-linked PNA lectin-binding assay of serum T-antigen in patients with SCC of the uterine cervix.
Reddi AL; Sankaranarayanan K; Arulraj HS; Devaraj N; Devaraj H
Cancer Lett; 2000 Feb; 149(1-2):207-11. PubMed ID: 10737726
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of squamous cell carcinoma antigen and ovarian carcinoma antigen (CA 125) in patients with benign and malignant diseases of the uterine cervix.
Gocze PM; Vahrson HW; Freeman DA
Oncology; 1994; 51(5):430-4. PubMed ID: 8052484
[TBL] [Abstract][Full Text] [Related]
3. Tn antigen, a marker of potential for metastasis of uterine cervix cancer cells.
Hirao T; Sakamoto Y; Kamada M; Hamada S; Aono T
Cancer; 1993 Jul; 72(1):154-9. PubMed ID: 8508399
[TBL] [Abstract][Full Text] [Related]
4. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
[TBL] [Abstract][Full Text] [Related]
5. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
Liu CZ; Zeng HX; Zhao JJ; Rong Y; Mo ZL; Li LA; Zhang JQ
Int J Gynecol Cancer; 2017 Jun; 27(5):994-1000. PubMed ID: 28498239
[TBL] [Abstract][Full Text] [Related]
6. High expression rate of Tn antigen in metastatic lesions of uterine cervical cancers.
Hamada S; Furumoto H; Kamada M; Hirao T; Aono T
Cancer Lett; 1993 Nov; 74(3):167-73. PubMed ID: 8174100
[TBL] [Abstract][Full Text] [Related]
7. Comparison between squamous cell carcinoma-associated antigen and CA-125 in patients with carcinoma of the cervix.
Lehtovirta P; Viinikka L; Ylikorkala O
Gynecol Oncol; 1990 May; 37(2):276-8. PubMed ID: 2344974
[TBL] [Abstract][Full Text] [Related]
8. The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy.
Ogino I; Nakayama H; Okamoto N; Kitamura T; Inoue T
Int J Gynecol Cancer; 2006; 16(3):1094-100. PubMed ID: 16803491
[TBL] [Abstract][Full Text] [Related]
9. Cancer of the uterine cervix: sensitivity and specificity of serum squamous cell carcinoma antigen determinations.
Duk JM; de Bruijn HW; Groenier KH; Hollema H; ten Hoor KA; Krans M; Aalders JG
Gynecol Oncol; 1990 Nov; 39(2):186-94. PubMed ID: 2227594
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125.
Verlooy H; Devos P; Janssens J; Mortelmans L; Gerits M; Bonte J; De Roo M
Gynecol Obstet Invest; 1991; 32(1):55-8. PubMed ID: 1765320
[TBL] [Abstract][Full Text] [Related]
11. A new enzyme-linked lectin/mucin antibody sandwich assay (CAM 17.1/WGA) assessed in combination with CA 19-9 and peanut lectin binding assay for the diagnosis of pancreatic cancer.
Parker N; Makin CA; Ching CK; Eccleston D; Taylor OM; Milton JD; Rhodes JM
Cancer; 1992 Sep; 70(5):1062-8. PubMed ID: 1515982
[TBL] [Abstract][Full Text] [Related]
12. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J
Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy.
Hong JH; Tsai CS; Chang JT; Wang CC; Lai CH; Lee SP; Tseng CJ; Chang TC; Tang SG
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):823-30. PubMed ID: 9652844
[TBL] [Abstract][Full Text] [Related]
14. SCC antigen in the serum as an independent prognostic factor in operable squamous cell carcinoma of the cervix.
Strauss HG; Laban C; Lautenschläger C; Buchmann J; Schneider I; Koelbl H
Eur J Cancer; 2002 Oct; 38(15):1987-91. PubMed ID: 12376202
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of measurement of SUVmax and SCC-antigen in patients with pretreatment of primary squamous cell carcinoma of cervix.
Nakamura K; Okumura Y; Kodama J; Hongo A; Kanazawa S; Hiramatsu Y
Gynecol Oncol; 2010 Oct; 119(1):81-6. PubMed ID: 20580064
[TBL] [Abstract][Full Text] [Related]
16. [Value of the assay of squamous cell carcinoma in cancer of the uterine cervix].
Gosselin P; Cazin JL; Dehaut JP; Sulman C; Baranzelli MC; Demaille MC
Presse Med; 1987 Oct; 16(34):1677-9. PubMed ID: 2959941
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma.
Avall-Lundqvist EH; Sjövall K; Nilsson BR; Eneroth PH
Eur J Cancer; 1992; 28A(10):1695-702. PubMed ID: 1389488
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
Huang EY; Hsu HC; Sun LM; Chanchien CC; Lin H; Chen HC; Tseng CW; Ou YC; Chang HY; Fang FM; Huang YJ; Wang CY; Lu HM; Tsai CC; Ma YY; Fu HC; Wang YM; Wang CJ
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1105-13. PubMed ID: 20932670
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of serum squamous cell carcinoma antigen in the diagnosis, treatment and prognosis of cervical squamous cell carcinoma].
Luan XM; Zhang Y; Wang SZ; Wang N; Li W; Zhang Q; Wei H; Zhang SL
Zhonghua Yi Xue Za Zhi; 2012 May; 92(19):1330-3. PubMed ID: 22883121
[TBL] [Abstract][Full Text] [Related]
20. Serum soluble interleukin-2 receptor (sIL-2R) assay in cervical and endometrial cancer. Preliminary data.
Ferdeghini M; Gadducci A; Prontera C; Marrai R; Malagnino G; Annicchiarico C; Fioretti P; Bianchi R
Anticancer Res; 1993; 13(3):709-13. PubMed ID: 8317901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
